PHarmaceutical tech@2x
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • PTF issue 99: Inside manufacturing inspections
    • Covid-19 impacting state and local tax revenues in US – leading macroeconomic influencers
    • WIRED Health:Tech 2020: challenges facing Covid-19 vaccines

    Most Recent

    Drug Development

    PTF issue 99: Inside manufacturing inspections

    25 Sep 2020
  • Investment

    Most Read

    • A guide to the key FDI drivers
    • How Covid-19 is affecting FDI regulations
    • The state of play: FDI in France

    Featured

    World Antibiotic Awareness Week: WHO highlights need for antimicrobial stewardship

    15 Nov 2018
  • Sectors

    Sections

    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
      • Respiratory

    Most Read

    • Positive CHMP opinion on baricitinib in atopic dermatitis positions it to take on Dupixent
    • PAH patients to benefit amid telemedicine regulatory changes in light of 2020 US election
    • Monte Rosa Therapeutics raises Series B funds for drug development

    Featured

    Clinical Trials

    M&As this week: Duran Group, Catalent Pharma Solutions

    15 Sep 2016
  • Deals

    Most Read

    • LEO Pharma divests four medicines to Cheplapharm for $357m
    • Bayer invests in cancer therapies developer Triumvira Immunologics
    • Engitix signs drug discovery and licensing deal with Takeda

    Featured

    Technology

    Boehringer partners with Click Therapeutics on schizophrenia therapeutic

    11 Sep 2020
  • Tech

    Most Read

    • Five must-read stories from the intersection of tech, business and politics
    • ‘Europe’s Digital Decade’: how the EU is pitching tech as the driving force behind its recovery
    • Five must-read stories from the intersection of tech, business and politics

    Featured

    Drug Development

    IFM Due signs immunotherapy deal with Novartis

    06 Sep 2019
  • Companies

    Sections

    • Company A-Z
    • Product & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Nymi™
    • Mimotopes
    • HOF Sonderanlagenbau

    Featured

    Manufacturing

    BERNHARDT

    21 May 2019
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Powder Handling
Tools
  • Companies
    • Company A-Z
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Reports
  • Awards
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register

Novartis’ migraine drug Aimovig gets EC approval

Novartis has obtained approval from the European Commission (EC) for the use of Aimovig (erenumab)...

1 August 2018

Latest News

Drug Development

Monte Rosa Therapeutics raises Series B funds for drug development

25 Sep 2020
Pharmaceuticals

Indivior lays out restructuring plans to cut down expenses

25 Sep 2020
Regulation

Gilead and Eisai obtain Japanese approval for RA drug Jyseleca

25 Sep 2020
Respiratory

RDIF and ChemRar agree to supply Avifavir to 17 countries

24 Sep 2020

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
logo-horizontal

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms & Conditions
  • Privacy Policy

© Copyright 2020 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.